
US community oncologists treating NSCLC were significantly more likely to be guideline adherent when providing first-line rather than adjuvant treatment.

US community oncologists treating NSCLC were significantly more likely to be guideline adherent when providing first-line rather than adjuvant treatment.

Published: March 12th 2013 | Updated:

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
